DaltonTx launches with £4m seed round from Redalpine, IQ Capital and Seedcamp to build the intelligence backbone of drug discovery

DaltonTx builds an adaptive AI platform for drug discovery that integrates directly into scientific workflows, helping research teams analyse data, design molecules and make decisions across small molecule and biologic programmes.